• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MRI Shows Low-Dose Methylene Blue Effect on Attention, Memory

Article

Functional MR imaging shows increased response in the brain after administration of low-dose methylene blue.

Functional MR imaging shows low-dose methylene blue can regulate certain brain networks related to sustained attention and short-term memory, according to a study published in Radiology.

Researchers from the University of Texas Health Science Center in San Antonio performed a prospective, randomized, double-blinded placebo controlled clinical trial to investigate the sustained-attention and memory-enhancing neural correlates of the oral administration of methylene blue in the healthy human brain.

Twenty-six subjects ranging from 22 to 62 years old participated in the study. They all underwent functional MR imaging while performing a psychomotor vigilance task (sustained attention) and delayed match-to-sample tasks (short-term memory) before and one hour after administration of low-dose methylene blue or a placebo. Cerebrovascular reactivity effects were also measured with the carbon dioxide challenge with methylene blue versus placebo, before versus after administration

“Although the memory-enhancing effects of methylene blue were shown in rodents in the 1970s, the underlying neuronal changes in the brain responsible for memory improvement and the effects of methylene blue on short-term memory and sustained-attention tasks have not been investigated,” study author Timothy Q. Duong, PhD, said in a release. “Our team decided to conduct the first multi-modal MRI study of methylene blue in humans.”[[{"type":"media","view_mode":"media_crop","fid":"50248","attributes":{"alt":"Timothy Q. Duong, PhD","class":"media-image media-image-right","id":"media_crop_2339403341898","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6121","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Timothy Q. Duong, PhD","typeof":"foaf:Image"}}]]

The results showed that administration of methylene blue increased the response in the bilateral insular cortex during a psychomotor vigilance task and functional MR imaging response during a short-term memory task involving the prefrontal, parietal, and occipital cortex. Methylene blue was also associated with a 7% increase in correct responses during memory retrieval.

The findings suggest that methylene blue can regulate certain brain networks related to sustained attention and short-term memory after a single oral low dose.

“This work certainly provides a foundation for future trials of methylene blue in healthy aging, cognitive impairment, dementia and other conditions that might benefit from drug-induced memory enhancement,” Duong said.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.